Prime Medicine Inc.

NASDAQ: PRME · Real-Time Price · USD
3.63
-0.01 (-0.27%)
At close: Aug 15, 2025, 2:58 PM

Prime Medicine Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-199.28M -202.01M -195.88M -219.25M -217.44M -204.5M -198.13M -171.77M -150.41M -137.38M -121.82M -145.45M -132.51M -102.55M -165.37M -104.98M -88.57M -91.72M
Depreciation & Amortization
6.26M 6.35M 6.13M 5.66M 5.34M 4.92M 4.65M 4.28M 3.67M 2.98M 2.22M 1.58M 1.12M 811K 568K 339K 172K 50K
Stock-Based Compensation
24.77M 18.45M 17.98M 16.46M 13.86M 17.44M 13.91M 12.05M 9.26M 7.02M 6.46M 4.99M 3.91M 2.66M 1.75M 795K 456K 518K
Other Working Capital
48.46M 37.54M 22.83M -11.4M -16.82M -22.61M 2.12M -9.31M -9.4M -2.02M -37.86M -7.12M -4.58M -5.47M 29.99M -1.49M -585K 122K
Other Non-Cash Items
15.7M 33.13M 45.05M 49.35M 38.5M 27.74M 16.43M 14.29M 11.34M 15.14M 17.68M 29.1M 37.71M 24.95M 99.9M 84.86M 75.42M 82.5M
Deferred Income Tax
n/a -134K n/a -4.64M -4.75M -4.59M -4.92M -481K -161K -634K -964K 481K -2.1M -1.66M -1.13M -2.37M n/a n/a
Change in Working Capital
52.44M 40.03M 17.58M -16.83M -18.01M -18.85M 2.65M -10.63M -16.88M -9.73M -35.4M -5.01M -1.94M -4.22M 30.2M -873K -93K 1.11M
Operating Cash Flow
-99.94M -104.02M -122.86M -182.97M -196.23M -191.56M -165.41M -152.26M -143.19M -122.59M -131.83M -114.3M -93.81M -80M -34.08M -22.23M -12.62M -7.54M
Capital Expenditures
-7.06M -7.39M -7.29M -7.34M -8.97M -9.05M -8.72M -11.7M -13.58M -16.41M -16.09M -11.66M -8.7M -4.82M -4.15M -3.77M -1.94M -1.02M
Cash Acquisitions
n/a n/a n/a -43.13K -8.26K -8.26K 2.4K 45.53K 19.39K 19.39K 8.72K 8.72K n/a n/a n/a n/a n/a n/a
Purchase of Investments
-48.76M -70.56M -129.45M -150.73M -195.2M -166.49M -104.95M -134.41M -94.25M -169M -123.34M -89.6M -80.8M -6.06M -6.06M -5.92M n/a n/a
Sales Maturities Of Investments
108.45M 134.7M 204.2M 218.84M 177.56M 170.06M 132.56M 110.02M 96M 95.5M 93M 81M 75M 45.5M 13M n/a n/a n/a
Other Investing Acitivies
1M 1M -33.71M -33.94M -34.7M -34.87M -172.4K -216.53K -190.39K -765.39K -673.72K -997.72K -881K -76.38M -76.42M -76.09M -76.2M 46K
Investing Cash Flow
53.62M 57.75M 68.46M 61.49M -26.62M -5.66M 18.71M -36.26M -12M -90.65M -47.1M -21.25M -15.38M -41.76M -73.63M -85.78M -78.14M -972K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
6.63M 6.47M 25.74M 25.93M 25.82M 25.86M 655K -720K -1.78M -2.48M -3.82M -3.73M -2.98M 265.69M 269.28M 280.35M 280.35M 12.29M
Financial Cash Flow
44.71M 44.55M 195.88M 196.07M 157.87M 157.91M 655K 184.53M 183.53M 182.83M 181.49M -3.67M -2.98M 265.69M 269.28M 280.35M 280.35M 22.27M
Net Cash Flow
-1.6M -1.72M 141.47M 74.58M -64.98M -39.3M -146.05M -3.99M 28.34M -30.41M 2.57M -139.22M -112.17M 143.93M 161.57M 172.34M 189.58M 13.76M
Free Cash Flow
-107M -111.41M -130.16M -190.32M -205.2M -200.61M -174.14M -163.96M -156.77M -139M -147.92M -125.96M -102.5M -84.82M -38.23M -26M -14.57M -8.56M